ChemoCentryx
CCXI
#3551
Rank
S$4.84 B
Marketcap
S$67.41
Share price
0.00%
Change (1 day)
29.36%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: S$4.84 Billion

On November 25, 2022 ChemoCentryx had a market cap of S$4.84 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022S$5.01 B45.41%
2021S$3.44 B-39.2%
2020S$5.66 B76.52%
2019S$3.21 B325.42%
2018S$0.75 B94.53%
2017S$0.38 B-24.2%
2016S$0.51 B1.13%
2015S$0.50 B29.12%
2014S$0.39 B24.62%
2013S$0.31 B-35.31%
2012S$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
S$33.44 B 589.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$511.01 B 10,440.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$124.15 B 2,460.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
S$133.69 B 2,657.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$624.67 B 12,784.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$219.13 B 4,419.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$186.74 B 3,751.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.48 B 776.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
S$313.80 B 6,372.41%๐Ÿ‡บ๐Ÿ‡ธ USA